Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Evaluation of pioneering introduction of integrative and prophetic medicine education in an Arabic medical school (Taibah University, Saudi Arabia): 10 years' experience.

Hamouda O, Sweilam M, Abdellah A, El Sayed SM.

J Int Med Res. 2019 May;47(5):2157-2165. doi: 10.1177/0300060519831174. Epub 2019 Apr 9.

2.

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort.

Machnowska P, Meixenberger K, Schmidt D, Jessen H, Hillenbrand H, Gunsenheimer-Bartmeyer B, Hamouda O, Kücherer C, Bannert N; German HIV-1 Seroconverter Study Group.

PLoS One. 2019 Jan 16;14(1):e0209605. doi: 10.1371/journal.pone.0209605. eCollection 2019.

3.

[Surveillance and Monitoring - Results of the Working Group 10 of the Forum Future Public Health, Berlin 2016].

Ziese T, Hamouda O.

Gesundheitswesen. 2017 Nov;79(11):932-935. doi: 10.1055/s-0043-121466. Epub 2017 Nov 24. German.

PMID:
29172222
4.

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors.

Meixenberger K, Yousef KP, Smith MR, Somogyi S, Fiedler S, Bartmeyer B, Hamouda O, Bannert N, von Kleist M, Kücherer C.

Virol J. 2017 Nov 14;14(1):223. doi: 10.1186/s12985-017-0887-1.

5.

Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.

Karo B, Krause G, Castell S, Kollan C, Hamouda O, Haas W; ClinSurv HIV Study Group.

BMC Infect Dis. 2017 Jul 25;17(1):517. doi: 10.1186/s12879-017-2627-y.

6.

Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014.

Hofmann A, Hauser A, Zimmermann R, Santos-Hövener C, Bätzing-Feigenbaum J, Wildner S, Kücherer C, Bannert N, Hamouda O, Bremer V, Bartmeyer B.

BMC Infect Dis. 2017 Jul 11;17(1):484. doi: 10.1186/s12879-017-2585-4.

7.

Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.

Chereau F, Madec Y, Sabin C, Obel N, Ruiz-Mateos E, Chrysos G, Fidler S, Lehmann C, Zangerle R, Wittkop L, Reiss P, Hamouda O, Estrada Perez V, Leal M, Mocroft A, Garcia De Olalla P, Ammassari A, D'Arminio Monforte A, Mussini C, Segura F, Castagna A, Cavassini M, Grabar S, Morlat P, De Wit S, Lambotte O, Meyer L; HIV Controllers Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCOORD.

PLoS One. 2017 Apr 5;12(4):e0173893. doi: 10.1371/journal.pone.0173893. eCollection 2017.

8.

Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014.

Dudareva-Vizule S, Haar K, Sailer A, Jansen K, Hamouda O, Wisplinghoff H, Tiemann C, Pape E, Bremer V; Chlamydia trachomatis laboratory sentinel team.

Euro Surveill. 2017 Feb 9;22(6). pii: 30459. doi: 10.2807/1560-7917.ES.2017.22.6.30459.

9.

STI tests and proportion of positive tests in female sex workers attending local public health departments in Germany in 2010/11.

Bremer V, Haar K, Gassowski M, Hamouda O, Nielsen S.

BMC Public Health. 2016 Nov 21;16(1):1175.

10.

High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).

Wenz B, Nielsen S, Gassowski M, Santos-Hövener C, Cai W, Ross RS, Bock CT, Ratsch BA, Kücherer C, Bannert N, Bremer V, Hamouda O, Marcus U, Zimmermann R; DRUCK Study group.

BMC Public Health. 2016 Sep 5;16:927. doi: 10.1186/s12889-016-3545-4.

11.

Inferring HIV-1 Transmission Dynamics in Germany From Recently Transmitted Viruses.

Pouran Yousef K, Meixenberger K, Smith MR, Somogyi S, Gromöller S, Schmidt D, Gunsenheimer-Bartmeyer B, Hamouda O, Kücherer C, von Kleist M.

J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):356-363.

PMID:
27400403
12.

The global spread of HIV-1 subtype B epidemic.

Magiorkinis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, Lawyer G, Hamouda O, Struck D, Vercauteren J, Wensing A, Alexiev I, Åsjö B, Balotta C, Gomes P, Camacho RJ, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kostrikis LG, Lepej SJ, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Schmit JC, Sönnerborg A, Staneková D, Stanojevic M, Stylianou DC, Boucher CAB; SPREAD program, Nikolopoulos G, Vasylyeva T, Friedman SR, van de Vijver D, Angarano G, Chaix ML, de Luca A, Korn K, Loveday C, Soriano V, Yerly S, Zazzi M, Vandamme AM, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:169-179. doi: 10.1016/j.meegid.2016.05.041. Epub 2016 Jun 2.

13.

Contamination during production of heater-cooler units by Mycobacterium chimaera potential cause for invasive cardiovascular infections: results of an outbreak investigation in Germany, April 2015 to February 2016.

Haller S, Höller C, Jacobshagen A, Hamouda O, Abu Sin M, Monnet DL, Plachouras D, Eckmanns T.

Euro Surveill. 2016 Apr 28;21(17). doi: 10.2807/1560-7917.ES.2016.21.17.30215.

14.

Impact of HIV infection on treatment outcome of tuberculosis in Europe.

Karo B, Krause G, Hollo V, van der Werf MJ, Castell S, Hamouda O, Haas W.

AIDS. 2016 Apr 24;30(7):1089-98. doi: 10.1097/QAD.0000000000001016.

PMID:
26752278
15.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ; SPREAD Program, Puchhammer-Stockl E, Sarcletti M, Schmied B, Geit M, Balluch G, Vandamme AM, Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Vandekerckhove LPR, Van den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Van Laethem K, Beshkov D, Alexiev I, Lepej SZ, Begovac J, Kostrikis L, Demetriades I, Kousiappa I, Demetriou V, Hezka J, Linka M, Maly M, Machala L, Nielsen C, Jørgensen LB, Gerstoft J, Mathiesen L, Pedersen C, Nielsen H, Laursen A, Kvinesdal B, Liitsola K, Ristola M, Suni J, Sutinen J, Descamps D, Assoumou L, Castor G, Grude M, Flandre P, Storto A, Hamouda O, Kücherer C, Berg T, Braun P, Poggensee G, Däumer M, Eberle J, Heiken H, Kaiser R, Knechten H, Korn K, Müller H, Neifer S, Schmidt B, Walter H, Gunsenheimer-Bartmeyer B, Harrer T, Paraskevis D, Hatzakis A, Zavitsanou A, Vassilakis A, Lazanas M, Chini M, Lioni A, Sakka V, Kourkounti S, Paparizos V, Antoniadou A, Papadopoulos A, Poulakou G, Katsarolis I, Protopapas K, Chryssos G, Drimis S, Gargalianos P, Xylomenos G, Lourida G, Psichogiou M, Daikos GL, Sipsas NV, Kontos A, Gamaletsou MN, Koratzanis G, Sambatakou H, Mariolis H, Skoutelis A, Papastamopoulos V, Georgiou O, Panagopoulos P, Maltezos E, Coughlan S, De Gascun C, Byrne C, Duffy M, Bergin C, Reidy D, Farrell G, Lambert J, O'Connor E, Rochford A, Low J, Coakely P, O'Dea S, Hall W, Mor O, Levi I, Chemtob D, Grossman Z, Zazzi M, de Luca A, Balotta C, Riva C, Mussini C, Caramma I, Capetti A, Colombo MC, Rossi C, Prati F, Tramuto F, Vitale F, Ciccozzi M, Angarano G, Rezza G, Kolupajeva T, Vasins O, Griskevicius A, Lipnickiene V, Schmit JC, Struck D, Sauvageot N, Hemmer R, Arendt V, Michaux C, Staub T, Sequin-Devaux C, Wensing AMJ, Boucher CAB, van de Vijver DAMC, van Kessel A, van Bentum PHM, Brinkman K, Connell BJ, van der Ende ME, Hoepelman IM, van Kasteren M, Kuipers M, Langebeek N, Richter C, Santegoets RMWJ, Schrijnders-Gudde L, Schuurman R, van de Ven BJM, Åsjö B, Kran AB, Ormaasen V, Aavitsland P, Horban A, Stanczak JJ, Stanczak GP, Firlag-Burkacka E, Wiercinska-Drapalo A, Jablonowska E, Maolepsza E, Leszczyszyn-Pynka M, Szata W, Camacho R, Palma C, Borges F, Paixão T, Duque V, Araújo F, Otelea D, Paraschiv S, Tudor AM, Cernat R, Chiriac C, Dumitrescu F, Prisecariu LJ, Stanojevic M, Jevtovic D, Salemovic D, Stanekova D, Habekova M, Chabadová Z, Drobkova T, Bukovinova P, Shunnar A, Truska P, Poljak M, Lunar M, Babic D, Tomazic J, Vidmar L, Vovko T, Karner P, Garcia F, Paredes R, Monge S, Moreno S, Del Amo J, Asensi V, Sirvent JL, de Mendoza C, Delgado R, Gutiérrez F, Berenguer J, Garcia-Bujalance S, Stella N, de Los Santos I, Blanco JR, Dalmau D, Rivero M, Segura F, Elías MJP, Alvarez M, Chueca N, Rodríguez-Martín C, Vidal C, Palomares JC, Viciana I, Viciana P, Cordoba J, Aguilera A, Domingo P, Galindo MJ, Miralles C, Del Pozo MA, Ribera E, Iribarren JA, Ruiz L, de la Torre J, Vidal F, Clotet B, Albert J, Heidarian A, Aperia-Peipke K, Axelsson M, Mild M, Karlsson A, Sönnerborg A, Thalme A, Navér L, Bratt G, Karlsson A, Blaxhult A, Gisslén M, Svennerholm B, Bergbrant I, Björkman P, Säll C, Mellgren Å, Lindholm A, Kuylenstierna N, Montelius R, Azimi F, Johansson B, Carlsson M, Johansson E, Ljungberg B, Ekvall H, Strand A, Mäkitalo S, Öberg S, Holmblad P, Höfer M, Holmberg H, Josefson P, Ryding U.

Clin Infect Dis. 2016 Mar 1;62(5):655-663. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

16.

High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany.

Jansen K, Thamm M, Bock CT, Scheufele R, Kücherer C, Muenstermann D, Hagedorn HJ, Jessen H, Dupke S, Hamouda O, Gunsenheimer-Bartmeyer B, Meixenberger K; HIV Seroconverter Study Group.

PLoS One. 2015 Nov 10;10(11):e0142515. doi: 10.1371/journal.pone.0142515. eCollection 2015.

17.

Twenty years of National Reference and Consultant laboratories for infectious diseases in Germany.

Vogel U, Beermann S, Gerlich W, Hamouda O, Kempf VA, Slack M.

Int J Med Microbiol. 2015 Oct;305(7):591-4. doi: 10.1016/j.ijmm.2015.08.006. Epub 2015 Aug 21. No abstract available.

PMID:
26363622
18.

Public health microbiology in Germany: 20 years of national reference centers and consultant laboratories.

Beermann S, Allerberger F, Wirtz A, Burger R, Hamouda O.

Int J Med Microbiol. 2015 Oct;305(7):595-600. doi: 10.1016/j.ijmm.2015.08.007. Epub 2015 Aug 21. Review.

PMID:
26321004
19.

Determinants of HIV, viral hepatitis and STI prevention needs among African migrants in Germany; a cross-sectional survey on knowledge, attitudes, behaviors and practices.

Santos-Hövener C, Marcus U, Koschollek C, Oudini H, Wiebe M, Ouedraogo OI, Thorlie A, Bremer V, Hamouda O, Dierks ML, An der Heiden M, Krause G.

BMC Public Health. 2015 Aug 6;15:753. doi: 10.1186/s12889-015-2098-2.

20.

So breitet sich HIV in Deutschland aus.

Hamouda O.

MMW Fortschr Med. 2015 Jun;157 Suppl 2:10-3. doi: 10.1007/s15006-015-3160-9. German. No abstract available.

PMID:
26048113
21.

S2k guideline* "Diagnosis and therapy of syphilis"--short version.

Schöfer H, Weberschock T, Bräuninger W, Bremer V, Dreher A, Enders M, Esser S, Hamouda O, Hagedorn HJ, Handrick W, Krause W, Mayr C, Münstermann D, Nast A, Ochsendorf F, Petry U, Potthoff A, Prange H, Rieg S, Schneede P, Sing A, Weber J, Wichelhaus TA, Brockmeyer N.

J Dtsch Dermatol Ges. 2015 May;13(5):472-80. doi: 10.1111/ddg.12574. No abstract available.

PMID:
25918100
22.

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany.

Schmidt D, Kollan C, Stoll M, Stellbrink HJ, Plettenberg A, Fätkenheuer G, Bergmann F, Bogner JR, van Lunzen J, Rockstroh J, Esser S, Jensen BE, Horst HA, Fritzsche C, Kühne A, an der Heiden M, Hamouda O, Bartmeyer B; ClinSurv Study Group.

BMC Public Health. 2015 Mar 17;15:252. doi: 10.1186/s12889-015-1598-4.

23.

Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia.

Angelis K, Albert J, Mamais I, Magiorkinis G, Hatzakis A, Hamouda O, Struck D, Vercauteren J, Wensing AM, Alexiev I, Åsjö B, Balotta C, Camacho RJ, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kostrikis LG, Lepej S, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Schmit JC, Sönnerborg A, Staneková D, Stanojevic M, Boucher CA, Kaplan L, Vandamme AM, Paraskevis D.

J Infect Dis. 2015 Jun 1;211(11):1735-44. doi: 10.1093/infdis/jiu666. Epub 2014 Dec 15.

PMID:
25512631
24.

Estimating the residual risk for HIV, HCV and HBV in different types of platelet concentrates in Germany.

an der Heiden M, Ritter S, Hamouda O, Offergeld R.

Vox Sang. 2015 Feb;108(2):123-30. doi: 10.1111/vox.12204. Epub 2014 Oct 21.

PMID:
25335096
25.

[National Cohort -- the largest health study in Germany].

Hamouda O, Krause G, Pigeot I.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Nov;57(11):1243-5. doi: 10.1007/s00103-014-2070-9. German. No abstract available.

PMID:
25323431
26.

Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany.

Schmidt D, Kollan C, Fätkenheuer G, Schülter E, Stellbrink HJ, Noah C, Jensen BE, Stoll M, Bogner JR, Eberle J, Meixenberger K, Kücherer C, Hamouda O, Bartmeyer B; ClinSurv-HIV Drug Resistance Study Group in CHAIN.

PLoS One. 2014 Aug 22;9(8):e104474. doi: 10.1371/journal.pone.0104474. eCollection 2014.

27.

A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling.

Zimmermann R, Marcus U, Schäffer D, Leicht A, Wenz B, Nielsen S, Santos-Hövener C, Ross RS, Stambouli O, Ratsch BA, Bannert N, Bock CT, Kücherer C, Hamouda O.

BMC Public Health. 2014 Aug 14;14:845. doi: 10.1186/1471-2458-14-845.

28.

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.

Frentz D, Van de Vijver DA, Abecasis AB, Albert J, Hamouda O, Jørgensen LB, Kücherer C, Struck D, Schmit JC, Vercauteren J, Åsjö B, Balotta C, Beshkov D, Camacho RJ, Clotet B, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Liitsola K, Linka M, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Stanekova D, Stanojevic M, Van Wijngaerden E, Wensing AM, Boucher CA; SPREAD Programme.

BMC Infect Dis. 2014 Jul 21;14:407. doi: 10.1186/1471-2334-14-407.

29.

Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.

Meixenberger K, Hauser A, Jansen K, Yousef KP, Fiedler S, von Kleist M, Norley S, Somogyi S, Hamouda O, Bannert N, Bartmeyer B, Kücherer C.

J Clin Microbiol. 2014 Aug;52(8):2977-83. doi: 10.1128/JCM.03289-13. Epub 2014 Jun 11.

30.

Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.

Hauser A, Santos-Hoevener C, Meixenberger K, Zimmermann R, Somogyi S, Fiedler S, Hofmann A, Bartmeyer B, Jansen K, Hamouda O, Bannert N, Kuecherer C.

PLoS One. 2014 Jun 3;9(6):e98038. doi: 10.1371/journal.pone.0098038. eCollection 2014.

31.

Conversation about Serostatus decreases risk of acquiring HIV: results from a case control study comparing MSM with recent HIV infection and HIV negative controls.

Santos-Hövener C, Zimmermann R, Kücherer C, Bätzing-Feigenbaum J, Wildner S, Hamouda O, Marcus U.

BMC Public Health. 2014 May 14;14:453. doi: 10.1186/1471-2458-14-453.

32.

First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study.

Zu Knyphausen F, Scheufele R, Kücherer C, Jansen K, Somogyi S, Dupke S, Jessen H, Schürmann D, Hamouda O, Meixenberger K, Bartmeyer B.

PLoS One. 2014 May 1;9(5):e95956. doi: 10.1371/journal.pone.0095956. eCollection 2014.

33.

Patterns of transmitted HIV drug resistance in Europe vary by risk group.

Frentz D, van de Vijver D, Abecasis A, Albert J, Hamouda O, Jørgensen L, Kücherer C, Struck D, Schmit JC, Vercauteren J, Asjö B, Balotta C, Bergin C, Beshkov D, Camacho R, Clotet B, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis L, Linka KL, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Stanekova D, Stanojevic M, Vandamme AM, Boucher C, Wensing A; SPREAD Programme.

PLoS One. 2014 Apr 10;9(4):e94495. doi: 10.1371/journal.pone.0094495. eCollection 2014.

34.

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors.

Karo B, Haas W, Kollan C, Gunsenheimer-Bartmeyer B, Hamouda O, Fiebig L; German ClinSurv HIV Study Group.

BMC Infect Dis. 2014 Mar 19;14:148. doi: 10.1186/1471-2334-14-148.

35.

Large multistate outbreak of norovirus gastroenteritis associated with frozen strawberries, Germany, 2012.

Bernard H, Faber M, Wilking H, Haller S, Höhle M, Schielke A, Ducomble T, Siffczyk C, Merbecks SS, Fricke G, Hamouda O, Stark K, Werber D; Outbreak Investigation Team.

Euro Surveill. 2014 Feb 27;19(8):20719.

36.

[Epidemiological developments of selected sexually transmitted infections in Germany].

Hamouda O, Bremer V, Marcus U, Bartmeyer B.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Dec;56(12):1600-8. doi: 10.1007/s00103-013-1866-3. German.

PMID:
24337121
37.

An assessment of the current Chlamydia trachomatis laboratory practices in Germany.

Schmidt D, Päschke H, Bremer V, Hamouda O, Reischl U, Sailer A, Haar K.

Gesundheitswesen. 2014 Oct;76(10):e44-50. doi: 10.1055/s-0033-1355406. Epub 2013 Nov 7.

PMID:
24203685
38.

Risk factors for Chlamydia trachomatis infection in adolescents: results from a representative population-based survey in Germany, 2003-2006.

Haar K, Bremer V, Houareau C, Meyer T, Desai S, Thamm M, Hamouda O.

Euro Surveill. 2013 Aug 22;18(34). pii: 20562.

39.

The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.

Hatzakis A, Van Damme P, Alcorn K, Gore C, Benazzouz M, Berkane S, Buti M, Carballo M, Cortes Martins H, Deuffic-Burban S, Dominguez A, Donoghoe M, Elzouki AN, Ben-Alaya Bouafif N, Esmat G, Esteban R, Fabri M, Fenton K, Goldberg D, Goulis I, Hadjichristodoulou C, Hatzigeorgiou T, Hamouda O, Hasurdjiev S, Hughes S, Kautz A, Malik M, Manolakopoulos S, Matičič M, Papatheodoridis G, Peck R, Peterle A, Potamitis G, Prati D, Roudot-Thoraval F, Reic T, Sharara A, Shennak M, Shiha G, Shouval D, Sočan M, Thomas H, Thursz M, Tosti M, Trépo C, Vince A, Vounou E, Wiessing L, Manns M.

J Viral Hepat. 2013 Aug;20 Suppl 2:1-20. doi: 10.1111/jvh.12120. Erratum in: J Viral Hepat. 2013 Oct;20(10):744. Hadjichristodoulou, T [corrected to Hadjichristodoulou, C].

PMID:
23827008
40.

[Activities related to STIs and HIV and data collection in German local health authorities, 2012 : can we harvest the data?].

Altmann M, Nielsen S, Hamouda O, Bremer V.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jul;56(7):922-9. doi: 10.1007/s00103-013-1763-9. German.

PMID:
23708861
41.

[Epidemiology of hepatitis A, B, and C among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

Poethko-Müller C, Zimmermann R, Hamouda O, Faber M, Stark K, Ross RS, Thamm M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):707-15. doi: 10.1007/s00103-013-1673-x. German.

PMID:
23703489
42.

Limited cross-border infections in patients newly diagnosed with HIV in Europe.

Frentz D, Wensing AM, Albert J, Paraskevis D, Abecasis AB, Hamouda O, Jørgensen LB, Kücherer C, Struck D, Schmit JC, Åsjö B, Balotta C, Beshkov D, Camacho RJ, Clotet B, Coughlan S, De Wit S, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Stanekova D, Stanojevic M, Vandamme AM, Boucher CA, Van de Vijver DA; SPREAD Programme.

Retrovirology. 2013 Apr 3;10:36. doi: 10.1186/1742-4690-10-36.

43.

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics.

Abecasis AB, Wensing AM, Paraskevis D, Vercauteren J, Theys K, Van de Vijver DA, Albert J, Asjö B, Balotta C, Beshkov D, Camacho RJ, Clotet B, De Gascun C, Griskevicius A, Grossman Z, Hamouda O, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Kücherer C, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Schmit JC, Sönnerborg A, Stanekova D, Stanojevic M, Struck D, Boucher CA, Vandamme AM.

Retrovirology. 2013 Jan 14;10:7. doi: 10.1186/1742-4690-10-7.

44.

HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data.

Fiebig L, Kollan C, Hauer B, Gunsenheimer-Bartmeyer B, An der Heiden M, Hamouda O, Haas W.

PLoS One. 2012;7(11):e49111. doi: 10.1371/journal.pone.0049111. Epub 2012 Nov 7.

45.

Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients.

Theys K, Deforche K, Vercauteren J, Libin P, van de Vijver DA, Albert J, Asjö B, Balotta C, Bruckova M, Camacho RJ, Clotet B, Coughlan S, Grossman Z, Hamouda O, Horban A, Korn K, Kostrikis LG, Kücherer C, Nielsen C, Paraskevis D, Poljak M, Puchhammer-Stockl E, Riva C, Ruiz L, Liitsola K, Schmit JC, Schuurman R, Sönnerborg A, Stanekova D, Stanojevic M, Struck D, Van Laethem K, Wensing AM, Boucher CA, Vandamme AM; SPREAD-programme.

Retrovirology. 2012 Oct 3;9:81. doi: 10.1186/1742-4690-9-81.

46.

[Prevention of nosocomial transmission of human immunodeficiency virus (HIV) from HIV-positive healthcare workers. Recommendations of the German Association for the Control of Viral Diseases (DVV) e.V. and the Society for Virology (GfV) e.V].

Rabenau HF, Gottschalk R, Gürtler L, Haberl AE, Hamouda O, Himmelreich H, Korn K, Mertens T, Schmidt KW, Schmiedel S, Spickhoff A, Wirz G, Wutzler P, Wicker S.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Aug;55(8):937-43. doi: 10.1007/s00103-012-1546-8. German.

PMID:
22842887
47.

[Demography and donation frequencies of blood and plasma donor populations in Germany. Update 2010 and 5-year comparison].

Ritter S, Hamouda O, Offergeld R.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Aug;55(8):914-22. doi: 10.1007/s00103-012-1515-2. German.

PMID:
22842884
48.

[HIV, HCV, HBV and syphilis surveillance among blood donors in Germany 2008-2010].

Offergeld R, Ritter S, Hamouda O.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Aug;55(8):907-13. doi: 10.1007/s00103-012-1516-1. German.

PMID:
22842883
49.

Syphilis on the rise again in Germany--results from surveillance data for 2011.

Bremer V, Marcus U, Hamouda O.

Euro Surveill. 2012 Jul 19;17(29). pii: 20222.

50.

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort.

Altmann M, An der Heiden M, Scheufele R, Hartmann K, Houareau C, Bartmeyer B, Hamouda O; German HIV-1 Seroconverter Cohort.

BMC Infect Dis. 2012 Apr 19;12:94. doi: 10.1186/1471-2334-12-94.

Supplemental Content

Loading ...
Support Center